Apatinib modulates sorafenib-resistant hepatocellular carcinoma through inhibiting the EGFR/JNK/ERK signaling pathway.
阿帕替尼通过抑制 EGFR/JNK/ERK 信号通路来调节索拉非尼耐药的肝细胞癌
期刊:Oncology Research
影响因子:4.1
doi:10.32604/or.2025.060407
Fan Dexue, Su Wei, Bi Zhaowen, Wang Xinxing, Xu Xianwen, Ma Mingze, Zhu Lichao, Zhang Zhenhai, Gao Junlin
信号转导
细胞生物学
MAPK/ERK
EGFR
JNK
肿瘤免疫
